DE60111637D1 - Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung - Google Patents

Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung

Info

Publication number
DE60111637D1
DE60111637D1 DE60111637T DE60111637T DE60111637D1 DE 60111637 D1 DE60111637 D1 DE 60111637D1 DE 60111637 T DE60111637 T DE 60111637T DE 60111637 T DE60111637 T DE 60111637T DE 60111637 D1 DE60111637 D1 DE 60111637D1
Authority
DE
Germany
Prior art keywords
hyaluronic acid
microspheres
utility
properties
tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111637T
Other languages
English (en)
Other versions
DE60111637T2 (de
Inventor
K Yamamoto
R Conston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iscience Corp
Original Assignee
Iscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iscience Corp filed Critical Iscience Corp
Publication of DE60111637D1 publication Critical patent/DE60111637D1/de
Application granted granted Critical
Publication of DE60111637T2 publication Critical patent/DE60111637T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
DE60111637T 2000-07-31 2001-07-31 Biomaterial in Form von Mikropartikeln von Hyaluronsäure zur medizinischen Verwendung Expired - Lifetime DE60111637T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62900000A 2000-07-31 2000-07-31
US629000 2000-07-31
PCT/US2001/024149 WO2002009787A1 (en) 2000-07-31 2001-07-31 Microparticulate biomaterial composition for medical use

Publications (2)

Publication Number Publication Date
DE60111637D1 true DE60111637D1 (de) 2005-07-28
DE60111637T2 DE60111637T2 (de) 2006-05-11

Family

ID=24521177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111637T Expired - Lifetime DE60111637T2 (de) 2000-07-31 2001-07-31 Biomaterial in Form von Mikropartikeln von Hyaluronsäure zur medizinischen Verwendung

Country Status (8)

Country Link
EP (1) EP1305057B1 (de)
JP (1) JP2004505065A (de)
AT (1) ATE298256T1 (de)
DE (1) DE60111637T2 (de)
DK (1) DK1305057T3 (de)
ES (1) ES2244641T3 (de)
PT (1) PT1305057E (de)
WO (1) WO2002009787A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
EP1753810B1 (de) 2004-05-27 2013-08-14 Novozymes Biopharma DK A/S Getrocknetes und agglomeriertes hyaluronsäureprodukt
US7956180B2 (en) 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
JP5526033B2 (ja) * 2007-11-14 2014-06-18 ザ ユニバーシティ オブ クィーンズランド 微粒子製造装置および微粒子製造方法
ITFI20130074A1 (it) * 2013-04-03 2014-10-04 Ambrosone Orazio Soluzione acquosa di contrasto per rendere visibile mediante metodica fotografica il canale di schlemm e le vie di deflusso dell¿umore acqueo e metodo diagnostico che utilizza detta soluzione.
JP7216006B2 (ja) 2017-03-22 2023-01-31 ジェネンテック， インコーポレイテッド ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法
CN114796619B (zh) * 2022-04-14 2023-03-14 珠海麦得发生物科技股份有限公司 可注射透明质酸微球及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
FR2759576B1 (fr) * 1997-02-17 1999-08-06 Corneal Ind Implant de sclero-keratectomie pre-descemetique
AU9313298A (en) * 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per

Also Published As

Publication number Publication date
EP1305057B1 (de) 2005-06-22
EP1305057A1 (de) 2003-05-02
DK1305057T3 (da) 2005-10-24
WO2002009787A1 (en) 2002-02-07
ATE298256T1 (de) 2005-07-15
JP2004505065A (ja) 2004-02-19
PT1305057E (pt) 2005-11-30
ES2244641T3 (es) 2005-12-16
DE60111637T2 (de) 2006-05-11

Similar Documents

Publication Publication Date Title
US9468779B2 (en) Viscoelastic gel for dermatological use
KR101779905B1 (ko) 충전제와 섬유아세포 성장 배지를 조합한 주사용 조성물
GEP20022804B (en) Erythropoietin Derivatives
ATE260651T1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
ES2155043B1 (es) Composiciones farmaceuticas comprendiendo acido pirimidin-5-il(3r, 5s)-3,5-dihidroxihept-6-enoico o una sal suya, su estabilizacion con sal fosfato tribasico y su preparacion.
US8648056B2 (en) Composition for local anesthesia
ATE424848T1 (de) Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen
DE60111637D1 (de) Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
ATE271886T1 (de) Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
KR102277655B1 (ko) 분말 형태로 첨가되는 리도카인 및 알칼리 제제를 포함하며 히알루론산을 기본 성분으로 하고 열에 의해 살균된, 주입가능한 하이드로겔의 수득 방법
US20130004546A1 (en) Hydrogel of microspheres
BR0015924A (pt) Compostos triaromáticos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
AP1919A (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
BR0015770A (pt) Compostos bicìclicos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
ITTO20010804A1 (it) Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
Taguchi et al. Evaluation of tumor tissue fixation effects of formulation modified Mohs pastes in mice and their water-absorbing properties
DE69736985D1 (de) Biologisch aktive zusammensetzung
JPH0597697A (ja) 歯槽骨再生剤
CN105535025A (zh) 嫩肤美白营养液及嫩肤美白组合物
EP3416652B1 (de) Injizierbare zusammensetzung, verfahren zur herstellung der zusammensetzung und verwendung der zusammensetzung
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
JP6656890B2 (ja) フィラグリン産生促進剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition